Boehringer Ingelheim Venture Fund

main navigation

jump to content to meta navigation
Headerillu Team

page content

jump to main navigation to meta navigation

Knut Elbers

Knut joined Boehringer Ingelheim in 1995 in the international research and development department of the animal health business. From 1999 to 2008 he was heading the European vaccine research organization for animal health. Subsequently he collected experiences in human antibody related research and development being involved in R&D project management and Collaborative Research for NBEs.

Knut Elbers

Dr. Knut Elbers

During his work at Boehringer Ingelheim Knut was involved in 12 patent applications and key development projects like (Ingelvac PRRSV, Enterisol Ileitis, Ingelvac CircoFLEX) contributing significantly to the vaccine business success of the animal health business of Boehringer Ingelheim.

Knut has studied biology at the Eberhard-Karls-University in Tübingen with specific focus on virology and immunology. He performed his Ph.D. work at the federal institute for viral diseases in Tübingen focusing on protein processing during viral replication and pathogen/host interaction mechanism.
back to top

Contact Venture Fund

  • Boehringer Ingelheim Venture Fund

    Backoffice
    Binger Strasse 173
    55216 Ingelheim am Rhein
    GERMANY